Overhaul of Medical Device Regs Announced

In an update to earlier announcements, the Medicines and Healthcare products Regulatory Agency has confirmed the implementation of a new regulatory framework for medical devices across Great Britain

CREDIT: This is an edited version of an article that originally appeared in Digital Health

This reform represents a major shift in how post-market surveillance (PMS) is carried out and marks a key part of the UK’s broader efforts to modernise and strengthen medical device safety following its departure from EU regulatory systems.

When Does it Come Into Effect?

The newly confirmed PMS regulations will apply to all UKCA- and CE-marked medical devices placed on the Great Britain market after 16 June 2025. This includes a broad range of devices used across healthcare settings, from in vitro diagnostic (IVD) tools such as glucose monitors to active implantable devices like pacemakers, as well as technologies routinely used in hospitals, clinics, and increasingly, in patients’ homes.

The core aim of the updated regulations is to ensure device manufacturers take greater responsibility for monitoring the performance and safety of their products once they are in use. This represents a shift from passive to active post-market surveillance, requiring manufacturers to systematically collect data, monitor device behaviour in real-world settings and act quickly when safety concerns arise.

What New Additions Are Being Made?

One of the most impactful additions is the introduction of trend reporting requirements, which will allow both the MHRA and manufacturers to identify recurring issues or potential risks earlier. This proactive approach aims to improve patient safety by addressing emerging problems before they escalate into more serious incidents.

The MHRA had already published preliminary guidance in January 2025, giving manufacturers early notice of the coming changes and offering direction on compliance expectations. Following industry consultation, this guidance has now been updated to reflect the final version of the regulations that are set to come into force in June 2025.

What Practice Managers Need to Know

For practice managers in primary care and community settings, these changes are significant. Many GP practices and health centres rely on medical devices that fall under this regulation, including diagnostics used in chronic disease management, point-of-care testing and home monitoring tools prescribed to patients. While manufacturers will be primarily responsible for compliance, practice managers will need to be aware of how these changes could affect procurement, incident reporting and the safety monitoring of medical technologies.

Moreover, understanding the regulatory framework is essential when communicating with suppliers, ensuring that only compliant and well-monitored devices are introduced into the practice setting. The changes also underscore the importance of reporting any adverse events or performance concerns with medical devices to manufacturers and the MHRA.

Ultimately, this regulatory update places patient safety, accountability and data-informed decision-making at the centre of how medical devices are managed in the UK. For practice managers, staying informed and engaged with these developments is critical – not only to ensure compliance, but also to support the safe and effective use of medical technologies in general practice.